WuXi PharmaTech (WX) Tops Q4 EPS by 10c; Guides FY14

March 5, 2014 4:31 PM EST Send to a Friend
WuXi PharmaTech (NYSE: WX) reported Q4 EPS of $0.53, $0.10 better than the analyst estimate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login